Reactive oxygen/nitrogen species suppress myocardial oxygen consumption. In this study, we determined that endogenous hydrogen peroxide through dismutation of superoxide enhances postischemic myocardial blood perfusion and oxygen consumption. Electron paramagnetic resonance oximetry was applied to monitor in vivo tissue Po 2 in mouse heart subjected to regional ischemia reperfusion. Heart rate, arterial blood pressure, blood flow, infarction, and activities of mitochondrial NADH dehydrogenase and cytochrome c oxidase were measured in six groups of wild-type (WT) and endothelial nitricoxide synthase knock-out (eNOS -bis(salicyclidene)ethylenediamine chloride], and SOD m plus glibenclamide to study the protective effect of hydrogen peroxide via dismutation of superoxide on the activation of sarcolemmal potassium channels. In the PBS group, there was an overshoot of tissue Po 2 after reperfusion. Treatment with SOD m , EUK134, and SOD m ϩ glibenclamide protected mitochondrial enzyme activities, reduced infarct size, and suppressed the postischemic hyperoxygenation. In particular, in the SOD m -treated group, there was a transient peak of tissue Po 2 at 9 min after reperfusion, which was dependent on endogenous hydrogen peroxide but not nitric oxide formation as it appeared in both WT and eNOS Ϫ/Ϫ mice. Blood flow and rate pressure product were higher in the SOD m group than in other groups, which contributed to the transient oxygen peak. Thus, SOD mimetics protected mouse heart from superoxide-induced reperfusion injury. With treatment of different SOD mimetics, it is concluded that endogenous hydrogen peroxide via dismutation of superoxide at reperfusion enhances postischemic myocardial blood perfusion and mitochondrial oxygen consumption, possibly through activation of sarcolemmal ATP-sensitive potassium channels.
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Myocardial ischemia and acute infarction arises secondary to atherosclerotic lesions followed by plaque rupture and thrombosis. Current treatments aim to terminate the ischemia by early re-establishment of blood flow. However, reperfusion may cause new damage to the region at risk (Rapapaport, 1989) . The generation of reactive oxygen/nitrogen (ROS/ RNS) species after reperfusion has been realized as one of the critical insults that trigger many of the observed mechanisms of cell injury (Zweier et al., , 1989 Kuppusamy and Zweier, 1994) . Among these ROS/RNS, NO, superoxide, and peroxynitrite are the most prominent oxidants. During the burst, NO may react with superoxide to generate peroxynitrite and cause a nonselective and irreversible inhibition of many mitochondrial components (Brown and Borutaite, 2002 ).
Yet another superoxide-related oxygen species, hydrogen peroxide, has long been recognized as one of the possible endothelium-derived hyperpolarizing factors (Matoba et al., 2000) . In normal aerobic mitochondrial metabolism, superoxide, as the byproduct of mitochondrial electron leakage (Wang et al., 2008) , is dismutated by superoxide dismutases in the mitochondria (matrix manganese SOD as well as intermembrane space SOD) to hydrogen peroxide, which plays an important role in cell signaling (Freeman and Crapo, 1982) . Hydrogen peroxide potentially dilates coronary arterial microvessels in both endothelium-dependent and independent manners (Thengchaisri and Kuo, 2003) . At the beginning of reperfusion following ischemia, there is a burst formation of NO from shear stress on endothelial cells and superoxide, mainly from mitochondria after re-establishment of the blood flow. The burst superoxide reacts with the burst NO at a diffusion-controlled rate to form the very potent oxidant peroxynitrite, thereby degrading the bioavailability of NO. Therefore, dismutation of superoxide would be beneficial to the postischemic heart by increasing the bioavailability of NO and reducing the detrimental effect of peroxynitrite. It would be ideal to selectively dismutate superoxide and convert it to a potential beneficial product because hydrogen peroxide has a number of beneficial effects as mentioned above.
SOD mimetic M40403 (SOD m ) is a very selective superoxide dismutase (Masini et al., 2002) . After intravenous injection, SOD m distributes widely into the heart, lungs, brain, liver, and kidneys while retaining its intact chemical identity (Salvemini et al., 1999) . It has been used as a selective superoxide dismutase in ischemia and reperfusion injury in rat heart to reduce the extent of myocardial damage, mast cell degranulation, and the incidence of ventricular arrhythmias. In our current study, SOD m was given to mice to selectively dismutate superoxide generated at the beginning of reperfusion to reduce peroxynitrite production. We also used EUK134, which has both SOD and catalase activities, to study its effect on postischemic tissue oxygenation and to differentiate the effect of hydrogen peroxide (Izumi et al., 2002) . If peroxynitrite contributes to the suppression of oxygen consumption, then by removing superoxide, the suppression of oxygen consumption should be reversed. In addition, we will test whether dismutation of superoxide and the subsequent formation of hydrogen peroxide will enhance the postischemic reperfusion and myocardial contractile function.
To determine the regulatory role of these ROS/RNS on mitochondrial respiration, oxygen consumption must be measured in the tissue in vivo. Tissue O 2 consumption can be determined by measuring the change in tissue O 2 supply and Po 2 . A significant overshoot of myocardial Po 2 was reported previously after release of the aortic cross-clamp during coronary bypass surgery; however, the mechanism was not shown (Al-Obaidi et al., 2000) . We demonstrated that the hyperoxygenation after reperfusion was due to the interaction of the burst NO and its derivative peroxynitrite on the mitochondrial respiration. In the prolonged high-level phase of Po 2 , peroxynitrite caused an irreversible change to the subcomponents of the mitochondrial respiratory chain, such as NADH dehydrogenase (NADH-DH) and cytochrome c oxidase (CcO) (Zhao et al., 2005) .
To measure tissue Po 2 in vivo, a reliable oximetry technique is required. Several techniques have been employed including fiber optic, lucigenin chemiluminescence, microelectrode, nuclear magnetic resonance, and recently developed electron paramagnetic resonance (EPR) oximetry techniques (Kreutzer and Jue, 1995; Xie et al., 1998; Clementi et al., 1999; He et al., 1999; Zhao et al., 1999; Dunn and Swartz, 2003; Pandian et al., 2003; Swartz and Dunn, 2003) . Among different techniques, microelectrode and EPR oximetry with particulates are the two direct ways to measure tissue Po 2 Swartz and Dunn, 2003) . However, with insertion of polarographic needles directly into tissue, microelectrode methods preclude repeated measurements. EPR oximetry, due to its noninvasive property, has emerged as a widely used method for measuring cellular, tissue, organ, and even whole-body tissue Po 2 in different models (He et al., 1999; Pandian et al., 2003) .
The current study will use EPR oximetry to measure tissue Po 2 in the in vivo mouse heart subjected to 30 min of regional ischemia and 60 min of reperfusion to study the regulatory role of mitochondria-derived superoxide and its derivative peroxynitrite on myocardial tissue oxygen consumption. EPR oximetry will also be used to determine whether it is NO or hydrogen peroxide that plays a significant role in the enhancement of the postischemic reperfusion and cardiac function after treatment of SOD m .
pletely ligated for 30 min in IR mice by tightening a 7-0 silk suture after passing it over a length of PE-10 tubing beneath the LAD at points 1 to 2 mm inferior to the left auricle. The 7-0 suture was similarly placed in the sham group but without LAD occlusion. The PE-10 tubing was ligated with the LAD to achieve easier ligature release and better reperfusion. Ischemia was confirmed visually by the appearance of pale and bulging myocardium in the area at risk (AAR). The ligature was removed, and reperfusion was visually confirmed after 30 min of LAD occlusion. Reperfusion was maintained for 60 min to obtain oximetry, blood flow, and hemodynamic measurements and 24 h for infarct size measurement.
EPR Oximetry. Approximately10 g of lithium phthalocyanine (LiPc, the oxygen-sensitive probe) was loaded in a 27-gauge needle and implanted in the midmyocardium of the AAR after the surgery. The location of the LiPc was confirmed by histology as in the midmyocardium in the area at risk. The mouse then was transferred to the L-band EPR spectrometer, and EPR spectra were collected after 30-min equilibration of the probe with the surrounding tissue before, during, and after ischemia and reperfusion with the following parameters: frequency, 1.1 GHz; microwave power, 16 mW; and modulation filed, 0.045 G. The sensitivity of the probe to tissue Po 2 is 5.8 mG/mm Hg.
Regional Blood Flow Measurement. An optical surface suction probe with a diameter of 2 mm (P10d; Moor Instruments, Devon, UK) was placed on the surface of the heart at the AAR to be able to move with the beating heart. The probe was connected to a laser Doppler tissue perfusion monitor (Moor Instruments) after thoracotomy and exposure of the heart. Blood flow was monitored during preischemia, 30-min ischemia, and 60-min reperfusion periods and the readings are expressed as a relative value without unit.
Hemodynamic Measurements. The right common carotid artery was cannulated with a PE-50 tubing tipped with 1-cm long PE-10 tubing. The cannula was attached to a transducer and monitor (PowerLab/400; ADInstruments Ltd., Chalgrove, Oxfordshire, UK) for analysis of mean arterial blood pressure (MABP) and heart rate (HR). The MABP was calculated as end diastolic arterial pressure ϩ (systolic arterial pressure Ϫ end diastolic arterial pressure)/3. The rate pressure product (RPP) was determined from the following formula: RPP ϭ MABP ϫ HR (in mm Hg per minute).
Activities of NADH-DH and CcO. Heart tissue from the risk area was excised, washed, and frozen immediately at the end of 60-min reperfusion. Tissue samples then were homogenized in icecold HEPES buffer (3 mM, pH 7.2) containing sucrose (0.25 M), EGTA (0.5 mM), and protease-inhibitor cocktail (1:40; Roche Diagnostics, Indianapolis, IN). NADH-DH activity was measured in the presence of Tris-HCl buffer (20 mM, pH 8.0), NADH (150 M; SigmaAldrich), and coenzyme Q 1 (100 M; Sigma-Aldrich). CcO activity was measured in the presence of phosphate buffer (50 mM, pH 7.4) and reduced cytochrome c (60 M; Sigma-Aldrich). The extinction coefficients, ε 340 nm ϭ 6.22 mM ⅐ cm for NADH and ε 550 nm ϭ 18.5 mM ⅐ cm for cytochrome c were used for activity calculation (Chen et al., 2004) . Protein concentration of the tissue homogenate was measured by the Lowry method, and the activities were normalized to protein concentrations as micromoles per minute per milligram protein.
Infarct Size. Twenty-four hours after ligation and reperfusion, animals were sacrificed with pentobarbital (50 mg/kg i.p.), and hearts were excised and cannulated through the ascending aorta with a 23-gauge needle for perfusion with 3 to 4 ml of 1.0% triphenyl tetrazolium chloride (TTC) in phosphate buffer (pH 7.4, 37°C). The LAD was reoccluded by tightening the suture left in the myocardium after IR and TTC staining. The hearts were then perfused with 2 to 3 ml of 2.5% Evans Blue (Sigma-Aldrich) to delineate nonischemic myocardium. The hearts were weighed, frozen, and cut into five transverse slices, each with ϳ1-mm thickness. Each slice was photographed from both sides with a high-resolution digital camera on a dissecting microscope. The sections were photographed and contoured with a planimeter (MetaVue Version 6.2r6) to delineate the borders of the entire heart, the nonischemic area, and the infarct area. The sizes of the AAR [total left ventricle (LV) area Ϫ nonischemic area] and the infarct area were calculated as percentages of the total LV area and the AAR multiplied by the total weight of that slice.
The time lines and protocols used for all of the experiments were indicated in Fig. 1 . Wild-type and eNOS Ϫ/Ϫ mice were subjected to 30 min of LAD occlusion followed by 60 min or 24 h of reperfusion as indicated with the open and closed boxes. For group 1 (n ϭ 7), intravenous bolus injection of PBS was given to wild-type mice 5 min before reperfusion as the sham control. In groups 2 (n ϭ 7), 5 (n ϭ 7), and 6 (n ϭ 7), wild-type mice were treated with intravenous bolus injection of SOD m , EUK134, SOD m plus glibenclamide 5 min before reperfusion. In groups 3 (n ϭ 7) and 4 (n ϭ 7), wild-type and eNOS Ϫ/Ϫ mice were treated with intravenous bolus injection of SOD m 30 min before ischemia.
Statistical Analysis. A two-way analysis of variance was used for analysis of Po 2 , mean arterial pressure, and RPP. A one-way analysis of variance was used for analysis of enzyme activities; these were followed by Newman-Keuls multiple-comparison test among the groups. A t test was used for analysis of AAR and infarct size. Data were represented as means Ϯ S.E. A value of p Ͻ 0.05 was considered significant.
Results
EPR Oximetry. EPR oximetry was performed before, during, and after 30-min ischemia and 60-min reperfusion on all groups of mice. As shown in Fig. 2A on wild-type mice treated with PBS, the value of tissue Po 2 before ischemia was measured as 12.0 Ϯ 1.3 mm Hg. At the end of 30-min ischemia, the value of tissue Po 2 reached a level of 0.7 Ϯ 0.1 mm Hg. After reperfusion, tissue Po 2 increased gradually and overshot the preischemic level. Previously, we have demonstrated that the overshoot of tissue Po 2 after reperfusion in the wild-type control mice was due to the suppression of mito-
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Group1: WT PBS sham control hearts.
Group2, 5, 6: WT hearts treated with SOD m , EUK134, SOD m plus Glib 5 min before reperfusion. After 30 min of stabilization, all mice underwent 30-min LAD occlusion followed by 60-min reperfusion represented with a sequence of white/black/white horizontal boxes. Group 1 (n ϭ 7), WT mice subjected to 30-min LAD occlusion and 60-min reperfusion with intravenous injection of PBS 5 min before reperfusion. Groups 2 (n ϭ 7), 5 (n ϭ 7), and 6 (n ϭ 7), WT mouse hearts subjected to 30-min ischemia and 60-min reperfusion with intravenous bolus infusion of SOD m , EUK134, and SOD m plus glibenclamide 5 min before reperfusion. Groups 3 (n ϭ 7) and 4 (n ϭ 7), eNOS Ϫ/Ϫ mouse hearts subjected to 30-min ischemia and 60-min reperfusion with intravenous bolus infusion of SOD m 30 min before ischemia. Additional groups of hearts were subjected to 30-min ischemia and 24-h reperfusion for measurements of infarct size and area at risk. chondrial oxygen consumption through endothelium-derived NO and its derivative peroxynitrite (Zhao et al., 2005) . When the mice were treated with SOD m 5 min before reperfusion, the hyperoxygenation status after reperfusion was suppressed ( Fig. 2B) . It is interesting that the Po 2 value went up initially and peaked at a value of 8.2 Ϯ 0.6 mm Hg at 9 min after reperfusion. After the transient peak, tissue Po 2 decreased to a level of 5.8 Ϯ 1.0 mm Hg at 20 min after reperfusion and then increased gradually. From the balance of supply and demand point of view, this transient peak could be due to a 2-fold reason; the increased blood flow at the beginning of reperfusion and the enhanced cardiac function after reperfusion therefore increased oxygen consumption afterward.
When the burst superoxide was dismutated with the treatment of SOD m , NO bioavailability should have increased. It has been reported that NO can reversibly inhibit mitochondrial oxygen consumption on the site of cytochrome c oxidase (Lizasoain et al., 1996; Loke et al., 1999) . To determine whether NO contributes to this transient peak of tissue Po 2 after treatment with SOD m , we performed EPR oximetry on eNOS Ϫ/Ϫ mice in which there is no production of NO after reperfusion. In addition, to clear out any potential transient impact of the delivery of the drug to the hemodynamics, we performed EPR oximetry on the mice treated with SOD m 30 min before ischemia, so the injection time point was far away from the reperfusion time that any unequilibrated drug delivery process would be ruled out. As shown in Fig. 3 , in the wild-type and eNOS Ϫ/Ϫ mice, SOD m treatment suppressed the hyperoxygenation status after reperfusion. Interestingly, there are similar transient peaks of tissue Po 2 after reperfusion in both the eNOS Ϫ/Ϫ as well as wild-type mice peaking at 9 min after reperfusion, which is obviously not dependent on the endothelium-derived NO.
The SOD m we used in the current study has been reported as a selective superoxide dismutase mimetic (Masini et al., 2002) . This means that the burst formation of superoxide after reperfusion (Zweier, 1988 ) is dismutated to hydrogen peroxide selectively by SOD m . It has also been reported that hydrogen peroxide can dilate vasculature in the heart and cause an increase of tissue blood perfusion (Burgoyne et al., 2007; Kokusho et al., 2007; Yada et al., 2008) . To test whether hydrogen peroxide contributes to this transient peak of tissue Po 2 after the treatment of SOD m , we performed Surgical procedures and EPR measurements were the same as described in Fig. 1 . SOD m was given as a bolus (4 mg/kg) at 30 min before ischemia. A, myocardial tissue Po 2 before and during ischemia and after reperfusion on WT SOD m -treated mouse hearts. There is a transient peak of tissue Po 2 at 9 min after reperfusion, even when SOD m was given 30 min before ischemia. B, myocardial tissue Po 2 before and during ischemia and after reperfusion on eNOS Ϫ/Ϫ SOD m -treated mouse hearts. The transient peak of Po 2 exists even in the eNOS Ϫ/Ϫ mouse hearts. n ϭ 7 for each group. These measurements demonstrated that the transient peak of tissue Po 2 after treatment with SOD m is independent of endothelium-derived NO.
Hydrogen Peroxide Enhances Oxygen Consumption 405
at ASPET Journals on January 28, 2018 jpet.aspetjournals.org
Downloaded from
EPR oximetry on the wild-type mice treated with EUK134, which is a superoxide dismutase mimetic with catalase activity (Izumi et al., 2002) . As shown in Fig. 4A , after treatment with EUK134 in the wild-type mice 5 min before reperfusion, there is no overshoot of tissue Po 2 , which indicates that the hyperoxygenation status was attenuated due to the dismutation of the burst formation of superoxide by EUK134 after reperfusion. Interestingly, the transient peak of tissue Po 2 at 9 min of reperfusion as shown in the control mice has also been suppressed. These data strongly suggested that the transient peak of tissue Po 2 after reperfusion with treatment of SOD m in the control group was due to the selective dismutation of the burst formation of superoxide and the subsequent formation of hydrogen peroxide.
To test that the endogenous hydrogen peroxide activates the sarcolemmal ATP-dependent potassium (sK ATP ) channels and protects the heart, we performed EPR oximetry on the wild-type mice treated with SOD m plus glibenclamide, which is an inhibitor of the sK ATP channels. As shown in Fig.  4B , the transient peak of tissue Po 2 after treatment with SOD m (Fig. 2B ) was suppressed after the addition of glibenclamide 5 min before reperfusion. These data suggested that hydrogen peroxide and the sK ATP channels are involved in the appearance of the transient peak of tissue Po 2 after treatment with SOD m .
Regional Blood Flow Measurement. To test our hypothesis that the selectively dismutated superoxide and subsequently formed hydrogen peroxide increases blood flow after reperfusion, blood perfusion in the area of risk was measured using a surface Doppler blood perfusion probe as described under Materials and Methods. As shown in Fig. 5 , A and B, the blood perfusion before ischemia was measured as 6.1 Ϯ 0.1, 6.0 Ϯ 0.1, 5.6 Ϯ 0.2, and 6.0 Ϯ 0.2 in PBS, SOD m , EUK134, and SOD m plus glibenclamide groups. After 30 min of regional ischemia, values of blood perfusion reached a similar level of 1.8 Ϯ 0.1, 1.8 Ϯ 0.2, 1.9 Ϯ 0.2, and 1.7 Ϯ 0.1 in PBS, SOD m , EUK134, and SOD m plus glibenclamide groups. After reperfusion, the value of blood perfusion reached a level of 4.9 Ϯ 0.3 in the SOD m group, which is significantly higher than that of 4.4 Ϯ 0.1, 4.5 Ϯ 0.4, and 4.2 Ϯ 0.2 in PBS, EUK134, and SOD m plus glibenclamide groups. The higher blood perfusion after treatment with SOD m was suppressed by additional treatment with glibenclamide, which is an inhibitor of the sK ATP channel. These . EPR oximetry on EUK134-and SODm ϩ Glib-treated mouse hearts. All experimental procedures are the same as described in Fig. 1 . EUK134 (10 mg/kg), SOD m (4 mg/kg), and glibenclamide (Glib, 2 mg/kg) were all given as a bolus at 5 min before reperfusion. A, myocardial tissue Po 2 before and during ischemia and after reperfusion on WT EUK134-treated mouse hearts. B, myocardial tissue Po 2 before and during ischemia and after reperfusion on WT SOD m ϩ Glib-treated mouse hearts. n ϭ 7 for each group. These measurements demonstrated that EUK134 treatment suppressed the hyperoxygenation in the WT control mouse hearts without the occurrence of the transient peak. In addition, glibenclamide treatment also suppressed the transient peak of Po 2 in the SOD m -treated mouse hearts. data suggested that the dismutation of superoxide and subsequent formation of hydrogen peroxide, as well as the sK ATP channels, are involved in the enhanced blood perfusion after reperfusion with treatment of SOD m . Hemodynamic Measurements. It has been demonstrated that openers of the sK ATP channels improved the cardiac reperfusion contractile function (Grover et al., 1991; Venkatesh et al., 1992) , whereas inhibitors of the channels suppressed the cardiac function (Grover et al., 1993) . To determine that dismutation of superoxide and subsequent formation of hydrogen peroxide enhances the cardiac reperfusion contractile function through activation of the sK ATP channels, we measured the HR and MABP and calculated the RPP, which is a hemodynamic index for cardiac contractile function and tissue oxygen consumption. As shown in Fig. 6 , A and B, the RPP values before ischemia were measured as 33195 Ϯ 1068, 32,471 Ϯ 1204, 33,484 Ϯ 2175, and 32,410 Ϯ 1411 mm Hg/min in PBS, SOD m , EUK134, and SOD m plus glibenclamide-treated mice. There was no significant difference among the groups. After 30 min of ischemia, the values of RPP reached similar levels of 21,197 Ϯ 1980, 21,478 Ϯ 1394, 22,524 Ϯ 1250, and 21 ,719 Ϯ 2064 mm Hg/min in these four groups, respectively. After reperfusion, the value of RPP showed a transient peak and reached a significantly higher level of 31,452 Ϯ 3126 mm Hg/min 2 min after reperfusion in the group treated with SOD m compared with that of the PBS (20,860 Ϯ 2440 mm Hg/min) and EUK134 (20,899 Ϯ 1462 mm Hg/min) groups. After the initial transient peak in the SOD m group, RPP values stayed significantly higher for the whole reperfusion time period ‫,ء(‬ p Ͻ 0.05 versus PBS and EUK134 groups). However, in the SOD m plus glibenclamidetreated group, the addition of glibenclamide attenuated the peak to a lesser extent of increase (26,600 Ϯ 2343 mm Hg/ min) compared with that of the SOD m group. It is interesting that the RPP values gradually decreased after the initial increase with the addition of glibenclamide reaching a level of 17,625 Ϯ 1525 mm Hg/min at 50-min reperfusion, which is significantly lower than that of the SOD m group (20,344 Ϯ 1358 mm Hg/min) at the corresponding time point. It is also noteworthy that there was no significant difference in the HR among all of the groups (data not shown). These data suggested that treatment with SOD m enhanced the reperfusion contractile function, and glibenclamide attenuated this enhancement. Therefore, dismutation of superoxide and subsequent formation of hydrogen peroxide as well as the sK ATP channels are involved in the enhancement of the reperfusion contractile function.
Activities of NADH-DH and CcO. The tissue blood perfusion and EPR oximetry data demonstrated that oxygen consumption in the PBS groups was greatly attenuated after reperfusion. Therefore, the restored tissue oxygen consumption and the preserved reperfusion contractile function in SOD m , EUK134, and SOD m plus glibenclamide groups required conserved oxygen consumption from the mitochondria. To test whether mitochondrial oxygen consumption and enzyme activities are improved after the treatment, we measured NADH-DH and CcO activities in the postischemic myocardium. As shown in Fig. 7, A These data demonstrated that, after ischemia reperfusion, the activities of NADH-DH and CcO were significantly reduced. With treatment of SOD m , EUK134, and SOD m plus glibenclamide, the activities of these two enzymes were restored to levels comparable to that before ischemia. Protein levels of these two enzymes were also measured (data not shown), and no difference was observed among the groups indicating that the modifications to the enzymes were post-translational. These data are consistent with the attenuation of the hyperoxygenation status after reperfusion in all of the treated groups.
Infarct Size. The ratio of AAR over the area of LV and infarct area over AAR was measured in the PBS, SOD m , and EUK134 groups. It was shown (Fig. 8 ) that there were no differences in the ratio of AAR among all of the groups. Infarct size was significantly lower in SOD m and EUK134 groups than that of the PBS group (22.7 Ϯ 2.4 and 27.6 Ϯ 1.5% versus 40.2 Ϯ 2.7%; ‫,ء‬ p Ͻ 0.05). These data confirmed the protection of SOD m and EUK134 on the postischemic myocardium. A, RPP on PBS and SOD m -treated mouse hearts before, during, and after ischemia and reperfusion. B, RPP on EUK134 and SOD m ϩ Glib-treated mouse hearts before, during, and after ischemia and reperfusion. These measurements demonstrated that with SOD m treatment, the value of RPP was significant higher compared with PBS-and EUK134-treated hearts, including an initial peak after 2 min of reperfusion. After treatment with SOD m plus glibenclamide, the value of RPP increased initially and then decreased after 25 min of reperfusion. At 50-min reperfusion, the value of RPP in the SOD m ϩ Glib hearts was significantly lower than that in the SODm-treated hearts. ‫,ء‬ p Ͻ 0.05, SOD m versus PBS and EUK134 after reperfusion; ‫,ءء‬ p Ͻ 0.05, SOD m versus SOD m ϩ Glib hearts at 50-min reperfusion, n ϭ 7.
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Discussion
It has been demonstrated that there was a burst formation of ROS/RNS, including NO (mainly from endothelial cells) and superoxide (mainly from mitochondria), at the very 1st min of reperfusion (Zweier, 1988; Wang and Zweier, 1996; Ferdinandy and Schulz, 2003) . The formation of peroxynitrite from NO and superoxide has been reported to suppress the mitochondrial oxygen consumption and attenuate the postischemic myocardial function (Zhao et al., 2005; Zhu et al., 2007) . Therefore, prevention of the formation of peroxynitrite and protection of the postischemic myocardial oxygen consumption may lead to salvage of the myocardium at risk. We have previously reported that inhibition of NO production protected the heart from ischemia reperfusion injury with the attenuation of the postischemic hyperoxygenation (Zhao et al., 2005) . However, NO has a number of protective effects, such as vasodilation, inhibition of platelet aggregation, and antiapoptotic effects, all leading to cardiac tissue protection. Therefore, antioxidant therapy targeting on superoxide formation would be more preferable. It has also been reported that hydrogen peroxide can vasodilate through activation of different surface potassium channels (Burgoyne et al., 2007; Kokusho et al., 2007) . Furthermore, the activation of the sK ATP channels has been reported to enhance the reperfusion cardiac contractile function (Grover et al., 1991) . Therefore, by using a selective SOD m (Masini et al., 2002) , dismutation of superoxide and subsequent formation of hydrogen peroxide may further improve the postischemic myocardial function.
In the current study, we have used different SOD mimetics to dismutate the burst formation of superoxide after ischemia reperfusion. EPR oximetry was applied to measure the in vivo tissue Po 2 after treatment with SOD m , EUK134, and SOD m plus glibenclamide. It was observed that the hyperoxygenation status after ischemia reperfusion was attenuated after all treatments. It is interesting that, with the treatment of SOD m , there was a transient peak of tissue Po 2 , which was independent of NO formation. Recently, it has been reported that hydrogen peroxide can activate protein kinase G and, therefore, activate sarcolemmal potassium channel and exert its hyperpolarization and vasorelaxation effect (Burgoyne et al., 2007) . Based on our EPR oximetry data, we hypothesize that selective dismutation of the burst formation of superoxide and subsequent formation of hydrogen peroxide at the beginning of reperfusion activates the sK ATP channels and, therefore, vasodilates and increases blood perfusion after reperfusion. With comparison to the treatment of EUK134, we hypothesized that the transient peak of tissue Po 2 was due to the formation of hydrogen peroxide via the dismutation of superoxide with the selective SOD m . The blood flow and hemodynamic measurements confirmed our hypothesis that the subsequent formation of hydrogen peroxide enhanced blood perfusion and cardiac contractile function after reperfusion. The data from the treatment of SOD m plus glibenclamide suggested that the transient peak of tissue Po 2 was possibly due to the opening of the sK ATP channels by hydrogen peroxide. As reported, the opening of the mitochondrial ATP-dependent potassium (mitoK ATP ) channels also protects the heart from ischemia reperfusion injury (Mozaffari and Schaffer, 2008) . The protective mechanism is due to the generation of reactive oxygen species to precondition the heart and the reduction of calcium overload in the mitochondria (Pasdois et al., 2007) . Glibenclamide can also inhibit the opening of the mitoK ATP channels, therefore, abrogating the protection. In our study, we coadministered glibenclamide with the SOD m . Our data showed that glibenclamide prevented the transient peak of tissue Po 2 due to its inhibitory effect on the increase of blood flow and enhancement of cardiac function after the treatment of the SOD m . These results suggested that the effect of glibenclamide in this study is more likely through the sK ATP channels, possibly in the endothelial and smooth muscle cells rather than the mitoK ATP channels in the myocyte mitochondria.
It has been reported that NO reversibly inhibited cytochrome c oxidase (Lizasoain et al., 1996) . Therefore, the interesting phenomenon of the transient peak of tissue Po 2 after treatment of SOD m in our oximetry studies could be due to the dismutation of superoxide; thus, more NO is available in the reperfused tissue. To determine whether NO is responsible for this transient oxygen peak, we have also performed the EPR oximetry on eNOS Ϫ/Ϫ mice. It was observed that the transient peak was not dependent on the bioavailability of NO. This result supported our hypothesis that the transient peak of tissue Po 2 was due to the formation of endogenous hydrogen peroxide. Figure 9 is the flow chart of our working hypotheses. In the uncontrolled situation with the burst formation of NO and superoxide, the oxidant peroxynitrite suppressed the mitochondrial oxygen consumption, degraded the contractile function, and therefore caused postischemic hyperoxygenation. Given that SOD m selectively dismutates the superoxide burst at the beginning of reperfusion, the subsequently formed hydrogen peroxide may activate protein kinase G subunit 1␣ and eventually open the sK ATP channels, which may increase blood perfusion to the risk area as well as enhance the cardiac contractile function. The increased blood perfusion at the beginning of reperfusion and enhanced cardiac function afterward may lead to the transient peak of tissue Po 2 as depicted from the EPR oximetry measurement in the SOD m group. When SOD m was used together with glibenclamide, the inhibitor of the sK ATP channels, the transient peak of tissue Po 2 was attenuated. Because EUK134 has both SOD and catalase activities, the treatment of EUK134 dismutates superoxide and reduces hydrogen peroxide to water, thus, decreasing tissue perfusion. So with the treatment of EUK134, it is expected that there will be no transient variations of tissue Po 2 but only the suppression of the hyperoxygenation status.
In vitro studies have shown that cytochrome c oxidase was reversibly inhibited by NO competing on the oxygen binding site (Lizasoain et al., 1996) . The same study has also demonstrated that NADH dehydrogenase was irreversibly inhibited by peroxynitrite probably through protein tyrosine nitration. Yet another recent study has demonstrated that NO can also irreversibly inhibit cytochrome c oxidase at low oxygen concentrations, possibly through the formation of nitroxyl anions (Parihar et al., 2008) . Our previous in vivo studies have demonstrated that both of these two enzymes were irreversibly inhibited after ischemia reperfusion (Zhu et al., 2007 ). In the current study, both of these two enzymes were also found to be inhibited after ischemia reperfusion, and treatment of SOD m restored the activities, which indicated that the inhibition is probably due to superoxide-derived peroxynitrite. Both SOD m and EUK134 can remove superoxide to protect ischemia-reperfusion heart, given the observation that in mitochondria there is no difference in activities of CcO and NADH-DH between the two treatments and the control group. SOD m generates H 2 O 2 via removing superoxide, increases cardiac function, and reperfuses the ischemic myocardium better. At the same time, SOD m may induce tachycardia through generation of hydrogen peroxide depending on the dosage used. Overdose of SOD m will certainly increase myocardial oxygen consumption abruptly in a short period of time; arrhythmia, circulatory derangement, or even death will occur. Although EUK134 reduces H 2 O 2 to 
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O 2 and H 2 O, it gives a less increment in blood reperfusion and less reinforcement in heart function than that of SOD m . In all, two SOD analogs were tested to afford protection to the ischemic and reperfused heart. With restricted dosage, SOD m (4 mg/kg or less) enhanced cardiac function and increased postischemic reperfusion.
In conclusion, SOD mimetics suppressed the burst formation of superoxide at the beginning of reperfusion and preserved mitochondrial oxygen consumption. With specific SOD m and the subsequent formation of hydrogen peroxide, myocardial tissue reperfusion was increased, and postischemic cardiac contractile function was enhanced. Our findings provide new insights into therapeutic strategies to target specific injurious ROS/RNS to prevent ischemia reperfusion injury and to salvage the myocardium at risk.
